University of Pennsylvania 8th annual conference on statistical issues in clinical trials: Pragmatic clinical trials (morning panel)

Hawkins JS Emanuel EJ (eds). Exploitation and developing countries: the ethics of clinical research. Princeton, NJ: Princeton University Press, 2008.

Corbie-Smith G. The continuing legacy of the Tuskegee Syphilis Study: considerations for clinical investigation. Am J Med Sci 1999; 317: 5–8.

Faden RR Lederer SE Moreno JD. US medical researchers, the Nuremberg Doctors Trial, and the Nuremberg Code: a review of findings of the Advisory Committee on Human Radiation Experiments. JAMA 1996; 276: 1667–1671.

Spector-Bagdady K Lombardo PA. “Something of an adventure”: postwar NIH research ethos and the Guatemala STD experiments. J Law Med Ethics 2013; 41: 697–710.

Office for Human Research Protections. Office of the Secretary: ethical principles and guidelines for the protection of human subjects of research. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html (1979, accessed 4 February 2016).

Wennberg J Gittelsohn A. Variations in medical care among small areas. Sci Am 1982; 246: 120–134.

Lantos JD. Vindication for SUPPORT. N Engl J Med 2015; 373: 1393–1395.

Annas GJ Grodin MA. The Nazi doctors and the Nuremberg Code: human rights in human experimentation. New York: Oxford University Press, 1992.

ClinicalTrials.gov. A cluster-randomized, pragmatic trial of hemodialysis session duration (TiME), https://clinicaltrials.gov/ct2/show/NCT02019225 (2013, accessed 4 February 2016).

Cho MK Magnus D Constantine M . Attitudes toward risk and informed consent for research on medical practices: a cross-sectional survey. Ann Intern Med 2015; 162: 690–696.

Institute of Medicine. Ethical review and oversight issues in research involving standard of care interventions: workshop in brief, http://www.nationalacademies.org/hmd/∼/media/MISPLACED-FILES-MAY-BREAK/StandardofCareWIB.pdf?la=en11 (2015, accessed 2 June 2016).

Gillespie SH Crook AM McHugh TD . Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis. N Engl J Med 2014; 371: 1577–1587.

Merle CS Fielding K Sow OB . A four-month gatifloxacin-containing regimen for treating tuberculosis. N Engl J Med 2014; 371: 1588–1598.

Jindani A Harrison TS Nunn AJ . High-dose rifapentine with moxifloxacin for pulmonary tuberculosis. N Engl J Med 2014; 371: 1599–1608.

Bellan SE Pulliam JR Pearson CA . Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. Lancet Infect Dis 2015; 15: 703–710.

Troxel AB Asch DA Volpp KG . Statistical issues in pragmatic trials of behavioral economic interventions. Clin Trials, in press.

Aysola J Troxel AB Asch DA . A randomized controlled trial of opt-in versus opt-out enrollment into a diabetes management intervention. Technical report, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 2015.

Connor JT Elm JJ Broglio KR ; ESETT and ADAPT-IT investigators, Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus. J Clin Epidemiol 2013; 66: S130–S137.

ClinicalTrials.gov. Automated hovering to improve medication adherence among myocardial infarction patients (Heartstrong), https://clinicaltrials.gov/ct2/show/NCT01800201?term=heartstrong&rank=1 (2013, accessed 5 February 2016).

GlowCap, http://www.glowcaps.com/product/ (2013, accessed 5 February 2016).

Home DM Pocock SJ Beck-Nielsen H . Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 2009; 373: 2125–2135.

Lieberman JA Stroup TS McEvoy JP . Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209–1223.

Ellenberg JH Ellenberg SS. Proceedings of the University of Pennsylvania 6th annual conference on statistical issues in clinical trials: dynamic treatment regimes. Clin Trials 2014; 11: 391–392.

Bassler D Montori VM Briel M . Early stopping of randomized clinical trials for overt efficacy is problematic. J Clin Epidemiol 2008; 61: 241–246.

Bassler D Briel M Montori VM . Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 2010; 303: 1180–1187.

Briel M Bassler D Wang AT . The dangers of stopping a trial too early. J Bone Joint Surg Am 2012; 94(Suppl. 1): 56–60.